Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.66B |
| 2 |
ORIG
Ocean Rig UDW Inc. Class A Common Shares
ORIG
|
+$1.55B |
| 3 |
RTX Corp
RTX
|
+$664M |
| 4 |
NXP Semiconductors
NXPI
|
+$606M |
| 5 |
Walt Disney
DIS
|
+$528M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$1.46B |
| 2 |
KKR & Co
KKR
|
+$602M |
| 3 |
Meta Platforms (Facebook)
META
|
+$594M |
| 4 |
Mastercard
MA
|
+$560M |
| 5 |
Visa
V
|
+$502M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.15% |
| 2 | Technology | 10.69% |
| 3 | Financials | 10.06% |
| 4 | Healthcare | 8.47% |
| 5 | Industrials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5251
Escalade
ESCA
$255M
| $203K | ﹤0.01% |
14,990
-2,526
| -14% | -$31.6K |
2013 Q2
17 quarters
|
|
|
ENFC
5252
DELISTED
Entegra Financial Corp.
ENFC
| $202K | ﹤0.01% |
8,092
+2,862
| +55% | +$66.6K |
2017 Q1
2 quarters
|
|
|
NW.PRC.CL
5253
DELISTED
Natwest Bank Ads Series C
NW.PRC.CL
| $202K | ﹤0.01% |
7,913
+1,986
| +34% | +$51.3K |
2015 Q4
7 quarters
|
|
|
PFNX
5254
DELISTED
Pfenex Inc.
PFNX
| $201K | ﹤0.01% |
66,534
-9,464
| -12% | -$36K |
2014 Q3
12 quarters
|
|
|
ROSE
5255
DELISTED
Rosehill Resources Inc. Class A
ROSE
| $201K | ﹤0.01% |
24,448
+2,372
| +11% | +$16.3K |
2017 Q2
1 quarter
|
|
|
EEI
5256
DELISTED
Ecology and Environment
EEI
| $201K | ﹤0.01% |
17,088
-400
| -2% | -$4.85K |
2013 Q2
17 quarters
|
|
5257
DELISTED
Ashford Inc.
AINC
| $200K | ﹤0.01% |
3,293
-1,318
| -29% | -$71.3K |
2014 Q4
11 quarters
|
|
5258
DELISTED
Paramount Global Class A
PARAA
| $199K | ﹤0.01% |
3,384
+50
| +1% | +$3.19K |
2013 Q4
15 quarters
|
|
5259
Permian Resources
PR
$20.6B
| $199K | ﹤0.01% |
11,114
-12,744
| -53% | -$213K |
2016 Q2
5 quarters
|
|
5260
ProShares Ultra Real Estate
URE
$49.9M
| $199K | ﹤0.01% |
3,144
+540
| +21% | +$34.3K |
2013 Q3
16 quarters
|
|
5261
European Equity Fund
EEA
$70M
| $197K | ﹤0.01% |
20,375
+629
| +3% | +$5.96K |
2013 Q4
15 quarters
|
|
5262
iShares MSCI Brazil Small-Cap ETF
EWZS
$321M
| $197K | ﹤0.01% |
11,621
+128
| +1% | +$1.98K |
2013 Q4
15 quarters
|
|
5263
Harte-Hanks
HHS
$32M
| $197K | ﹤0.01% |
18,350
-10,203
| -36% | -$93.9K |
2013 Q2
17 quarters
|
|
5264
vTv Therapeutics
VTVT
$105M
| $197K | ﹤0.01% |
821
+26
| +3% | +$5.18K |
2016 Q3
4 quarters
|
|
|
SNMP
5265
DELISTED
Evolve Transition Infrastructure LP
SNMP
| $197K | ﹤0.01% |
583
-67
| -10% | -$21.8K |
2015 Q2
9 quarters
|
|
|
GSV
5266
DELISTED
Gold Standard Ventures Corp.
GSV
| $197K | ﹤0.01% |
121,765
+121,340
| +28,551% | +$209K |
2016 Q3
4 quarters
|
|
|
POPE
5267
DELISTED
Pope Resources Depositary Receipts of Limited Partnership Units
POPE
| $197K | ﹤0.01% |
2,810
+356
| +15% | +$25.5K |
2013 Q2
17 quarters
|
|
5268
DELISTED
Legacy Reserves Inc. Common Stock
LGCY
| $197K | ﹤0.01% |
129,269
+20,226
| +19% | +$26.2K |
2013 Q2
17 quarters
|
|
|
ZSAN
5269
DELISTED
Zosano Pharma Corporation
ZSAN
| $196K | ﹤0.01% |
341
-100
| -23% | -$73.3K |
2017 Q1
2 quarters
|
|
5270
DELISTED
Town Sports International Holdings, Inc.
CLUB
| $196K | ﹤0.01% |
27,986
-4,714
| -14% | -$26.3K |
2013 Q2
17 quarters
|
|
5271
Peoples Bancorp of North Carolina
PEBK
$236M
| $195K | ﹤0.01% |
6,007
+1,949
| +48% | +$56.3K |
2013 Q4
15 quarters
|
|
|
SBBP
5272
DELISTED
Strongbridge Biopharma plc.
SBBP
| $195K | ﹤0.01% |
28,269
+8,026
| +40% | +$55.4K |
2017 Q1
2 quarters
|
|
5273
Standard BioTools
LAB
$247M
| $194K | ﹤0.01% |
38,618
+8,946
| +30% | +$37.6K |
2013 Q2
17 quarters
|
|
5274
Unity Bancorp
UNTY
$568M
| $194K | ﹤0.01% |
9,821
+1,973
| +25% | +$35.5K |
2014 Q1
14 quarters
|
|
5275
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $194K | ﹤0.01% |
1,680
+275
| +20% | +$33K |
2014 Q1
14 quarters
|
|
Similar funds
Morgan Stanley's Q3 2017 Portfolio in Review
As of Q3 2017, Morgan Stanley held 6,889 positions worth $334B, up 0.86% from $331B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley's Q3 2017 filing shows 195 new, 3,466 increased, 2,508 reduced and 247 closed positions. Its largest new stake was JBG SMITH: 4,306,383 shares worth $147M. The largest sale was Reynolds American Inc, an estimated $1.46B.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 31% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q3 2017 buy was JBG SMITH: 4,306,383 shares worth $147M.
- Morgan Stanley added most to iShares MSCI Emerging Markets ETF in Q3 2017, an estimated $1.66B increase.
- Morgan Stanley's biggest Q3 2017 reduction was KKR & Co, cutting an estimated $602M.
- Morgan Stanley fully exited Reynolds American Inc in Q3 2017, selling an estimated $1.46B.
- Morgan Stanley's ten largest holdings make up 12% of its $334B portfolio in Q3 2017.
- Morgan Stanley opened 195 new positions and closed 247 in Q3 2017.
- Morgan Stanley's portfolio value rose 0.86% quarter-over-quarter to $334B.
Based on Morgan Stanley's 13F filing for Q3 2017, filed 14 Nov 2017.